Zobrazeno 1 - 10 of 53 pro vyhledávání: '"Erik M. van Maarseveen"'
1
Akademický článek
Quantification of neutralizing anti-drug antibodies and their neutralizing capacity using competitive displacement and tandem mass spectrometry: Infliximab as proof of principle
Autor: Mohsin El Amrani, Camiel Göbel, Annelies C. Egas, Stefan Nierkens, C. Erik Hack, Alwin D.R. Huitema, Erik M. van Maarseveen
Publikováno v: Journal of Translational Autoimmunity, Vol 1, Iss , Pp - (2019)
Background: The development of anti-drug antibodies (ADA) in patients treated with therapeutic proteins can result in treatment failure. The clinically most relevant fraction of these antibodies are the neutralizing anti-drug antibodies (NAb) that bl
Externí odkaz: https://doaj.org/article/233fb804500e42faa13ec88e51fbb4c0
Zobrazit plný text záznamu
2
High efavirenz levels but not neurofilament light plasma levels are associated with poor neurocognitive functioning in asymptomatic HIV patients
Autor: Erik M. van Maarseveen, Charlotte E. Teunissen, Anne Marie Hermans, Andy I. M. Hoepelman, C. S. Hakkers, Inge M.W. Verberk, Joop E. Arends
Publikováno v: JOURNAL OF NEUROVIROLOGY, 26(4), 572-580. Taylor and Francis Ltd.
Hakkers, C S, Hermans, A M, van Maarseveen, E M, Teunissen, C E, Verberk, I M W, Arends, J E & Hoepelman, A I M 2020, ' High efavirenz levels but not neurofilament light plasma levels are associated with poor neurocognitive functioning in asymptomatic HIV patients ', JOURNAL OF NEUROVIROLOGY, vol. 26, no. 4, pp. 572-580 . https://doi.org/10.1007/s13365-020-00860-1
Journal of Neurovirology
The aim of this study is to assess the effect of efavirenz exposure on neurocognitive functioning and investigate plasma neurofilament light (Nfl) as a biomarker for neurocognitive damage. Sub-analysis of the ESCAPE-study, a randomised controlled tri
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7e11143f0cfcdbd9767d62d29cd151d
https://doi.org/10.1007/s13365-020-00860-1
Zobrazit plný text záznamu
3
Clinical Trial Simulation To Optimize Trial Design for Fludarabine Dosing Strategies in Allogeneic Hematopoietic Cell Transplantation
Autor: Jaap Jan Boelens, Alwin D. R. Huitema, Stefan Nierkens, Thomas P. C. Dorlo, Moniek de Witte, Charlotte van Kesteren, Erik M. van Maarseveen, Jurgen Langenhorst
Publikováno v: CPT: Pharmacometrics & Systems Pharmacology
CPT: Pharmacometrics & Systems Pharmacology, Vol 9, Iss 5, Pp 272-281 (2020)
Optimal fludarabine exposure has been associated with improved treatment outcome in allogeneic hematopoietic cell transplantation, suggesting potential benefit of individualized dosing. A randomized controlled trial (RCT) comparing alternative fludar
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a54462b4bd1c70b65d9f40809ca6ee7
http://europepmc.org/articles/PMC7239337
Zobrazit plný text záznamu
4
A semi‐mechanistic model based on glutathione depletion to describe intra‐individual reduction in busulfan clearance
Autor: Erik M. van Maarseveen, Antoine C. G. Egberts, Charlotte van Kesteren, Alwin D. R. Huitema, Jaap Jan Boelens, Jürgen Kuball, Jill Boss, Arief Lalmohamed, Jurgen Langenhorst
Publikováno v: British Journal of Clinical Pharmacology
British Journal of Clinical Pharmacology, 86(8), 1499. NLM (Medline)
Aim To develop a semi-mechanistic model, based on glutathione depletion and predict a previously identified intra-individual reduction in busulfan clearance to aid in more precise dosing. Methods Busulfan concentration data, measured as part of regul
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5016b81eac9727f7c897640518e09d5c
https://doi.org/10.1111/bcp.14256
Zobrazit plný text záznamu
5
Clinical Pharmacokinetics and Impact of Hematocrit on Monitoring and Dosing of Tacrolimus Early After Heart and Lung Transplantation
Autor: Dylan W. de Lange, Erik M. van Maarseveen, Maaike A. Sikma, Alwin D. R. Huitema, Claudine C. Hunault
Publikováno v: Clinical Pharmacokinetics
Clinical Pharmacokinetics, 59(4), 403. Adis International Ltd
The calcineurin inhibitor tacrolimus is an effective immunosuppressant and is extensively used in solid organ transplantation. In the first week after heart and lung transplantation, tacrolimus dosing is difficult due to considerable physiological ch
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b587fe851131b4f94d91c529fe3d766
https://doi.org/10.1007/s40262-019-00846-1
Zobrazit plný text záznamu
6
Development and Validation of Hematocrit Level Measurement in Dried Blood Spots Using Near-Infrared Spectroscopy
Autor: Mariam Boussaidi, Henk Russcher, Daan van de Velde, Brenda C. M. de Winter, Erik M. van Maarseveen, Dennis A. Hesselink, Ruud Huisman, Annelies C Kooij-Egas, Jordy L van der Graaf
Publikováno v: Therapeutic Drug Monitoring, 43(3), 351-357. Lippincott Williams & Wilkins
BACKGROUND: Dried blood spots (DBSs) have gained recent popularity as a sampling method for therapeutic drug monitoring. For patients, DBS sampling has several advantages over venous blood sampling. However, technical issues primarily influenced by h
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2908028ff1cd12efd37163d12405f7da
https://pure.eur.nl/en/publications/07bccffb-14cc-467b-8301-23fe3d2296ec
Zobrazit plný text záznamu
7
Simultaneous Quantification of Free Adalimumab and Infliximab in Human Plasma Using a Target-Based Sample Purification and Liquid Chromatography–Tandem Mass Spectrometry
Autor: C. Erik Hack, Sabine M Bosman, Mohsin El Amrani, Erik M. van Maarseveen, Alwin D. R. Huitema, Annelies C. Egas
Publikováno v: Therapeutic Drug Monitoring, 41(5), 640. Lippincott Williams and Wilkins
BACKGROUND: Therapeutic drug monitoring of tumor necrosis factor alpha (TNF-α) inhibitors such as adalimumab (ADM) and infliximab (IFX) is considered of added value for patients with systemic inflammatory diseases. In contrast to enzyme-linked immun
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a32a8804391a4a1e8bac9e9fc708f85d
https://doi.org/10.1097/ftd.0000000000000633
Zobrazit plný text záznamu
9
Nonlinear protein binding of phenytoin in clinical practice: Development and validation of a mechanistic prediction model
Autor: Erik M. van Maarseveen, Matthew D. Krasowski, Sean P. Kane, Alwin D. R. Huitema, Rob ter Heine
Publikováno v: British Journal of Clinical Pharmacology, 85(10), 2360. Wiley-Blackwell
British Journal of Clinical Pharmacology, 85, 10, pp. 2360-2368
Br J Clin Pharmacol
British Journal of Clinical Pharmacology, 85, 2360-2368
Item does not contain fulltext AIMS: To individualize treatment, phenytoin doses are adjusted based on free concentrations, either measured or calculated from total concentrations. As a mechanistic protein binding model may more accurately reflect th
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc3733bfb0db416e02e77676bdf8103f
https://doi.org/10.1111/bcp.14053
Zobrazit plný text záznamu
10
Association of adalimumab trough concentrations and treatment response in patients with juvenile idiopathic arthritis
Autor: Joost F. Swart, Nico M Wulffraat, Sytze de Roock, Erik M. van Maarseveen, Mohsin El Amrani, Martijn J. H. Doeleman
Publikováno v: Rheumatology (Oxford, England). 61(1)
Objective The objective of this study was to assess the relationship between adalimumab trough concentrations and treatment response in paediatric patients with JIA. Methods This was a monocentric cohort study of JIA patients treated with adalimumab.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9cc7c470f04229dd2746fe85f6ce90b
https://pubmed.ncbi.nlm.nih.gov/33878159
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje